Progesterone gel - Catalent
At a glance
- Drug Originator Columbia Laboratories
- Drug Licenced by AbbVie; Merck KGaA
- Drug Class Hormonal contraceptives; Hormonal replacements; Infertility therapies; Pregnenediones; Small molecules
- Mechanism of Action Progesterone receptor agonists
- USA Patent Applicants ABBVIE
- USA Patents 2
- NDAs 1
- Patent Applications 4,286
Table of Contents
Disclaimer